Data in Healthcare: Underpinning the Shift to Value
Data in Healthcare: Underpinning the Shift to Value
Data underpins the shift to value-based care underway across health systems. The many kinds of health and health-relevant data vary in complexity, strengths and weaknesses, and are typically owned by different stakeholders.
MAPPING THE HEALTH DATA LANDSCAPE
Data underpins the shift to value-based care underway across health systems.
The many kinds of health and health-relevant data vary in complexity, strengths and weaknesses, and are typically owned by different stakeholders. Provider-run electronic health records lie at the heart of the health data universe, yet structured payer claims data is also key to the shift to value-based care. Genomics data and digital-technology-derived data sources are proliferating.
VALUE-BASED CARE IS CHANGING THE DATA LANDSCAPE
The demand for high-quality data to enable the shift to value-based care has created a vibrant data market, which has attracted a growing range of data crunchers and solution providers, both large established groups and small start-ups. There is now more data, and better data, than ever before. Interoperability is improving slowly, and efforts are underway to combine disparate sources such as clinical and claims data, thereby providing a full picture of the patient care journey. Pharma firms are tapping into multiple data types to improve R&D efficiency and optimize market access.
CHALLENGES FACING THE DATA MARKET
Challenges facing the data market lie around data collection, quality, sharing, standards, governance, security and access, privacy, validation, application, and around the mindset shift required within provider and pharma organizations in particular, to take full advantage of the growing data-driven insights available.
POPULATION HEALTH MANAGEMENT: USING DATA TO CONTROL COSTS AND MANAGE DISEASE
Much of the health data being collected is intended to help improve care and outcomes, be it through better, more targeted disease treatment and management, more effective prevention, and/or improved cost controls. Pharma is using better data – mostly genomic sequencing data – to develop more targeted treatments for individuals. Providers and payers are using a far broader range of data and sophisticated analytics tools to more effectively manage the health of their covered populations – known as population health management. Key to that is risk-stratification – figuring out which are the 20% of patients at high risk of adverse events. The more integrated and holistic the data available to tap into, the more accurate the risk-stratification will be – and the more appropriately interventions can be targeted to help manage or reduce that risk.
HURDLES TO POPULATION HEALTH MANAGEMENT
Hurdles to population health management include variable pharmaceutical pricing; the challenge, for physicians and other providers, of actually using data to inform decision-making; implementing the shift from a treatment toward a prevention mentality; and the controversy around using social and behavioral data in a healthcare setting.
PHARMA NEEDS CROSS-FUNCTIONAL DATA CAPABILITIES
Pharmaceutical firms must develop broader data-focused expertise across all of their functions. Data is increasingly part of an overall, corporate-wide strategy, underpinned by significant investment and new kinds of deals to generate and access richer data – and/or make better use of existing data. A new role – that of the data scientist – has evolved: an expert in extracting insights from data and in building predictive models. Focus remains critical though, as data is only useful if it answers a specific, well-articulated need.
TABLE OF CONTENTS
5 EXECUTIVE SUMMARY
5 Mapping the health data landscape
5 Value-based care is changing the data landscape
5 Challenges facing the data market
5 Population health management: using data to control costs and manage disease
5 Hurdles to population health management
5 Pharma needs cross-functional data capabilities
7 MAPPING THE HEALTHCARE DATA LANDSCAPE
7 Data underpins the shift to value
7 A healthcare data taxonomy
12 VALUE-BASED CARE IS CHANGING THE DATA LANDSCAPE
12 Demand for data creates a vibrant market
13 Boon for data crunchers and solution providers
23 CHALLENGES FACING THE DATA MARKET
23 Data collection
23 Data quality
24 Data sharing
24 Data standards
24 Data governance
25 Data security and access
25 Data privacy
25 Data validation
25 Data application and the culture shift
28 POPULATION HEALTH MANAGEMENT: USING DATA TO CONTROL COSTS AND MANAGE DISEASE
28 Risk-stratifying patients to better manage costs and outcomes
30 Hurdles to population health management
34 PHARMA NEEDS CROSS-FUNCTIONAL DATA CAPABILITIES
34 Sharing data across the organization
34 Growing the “data scientist”
35 Data dealmaking
35 Asking the right questions
36 Data-driven shift in healthcare is underway
38 About the author
LIST OF FIGURES
12 Figure 1: Roles of different healthcare stakeholders and players within the data landscape
LIST OF TABLES
8 Table 1: Categories of healthcare data
14 Table 2: Selected data-focused start-ups supporting healthcare stakeholders
23 Table 3: Challenges facing the data market
31 Table 4: Hurdles to population health management
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email email@example.com for further help or assistance.